Artisan Partners logo

Artisan Partners

North America, Wisconsin, United States, Milwaukee

Description

Artisan Partners is a global investment management firm.

Investor Profile

Artisan Partners has made 2 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Post Ipo Equity (50%)
  • Series Unknown (50%)

Country Focus

  • Sweden (50%)
  • India (50%)

Industry Focus

  • Biotechnology
  • Clinical Trials
  • Pharmaceutical
  • E-learning
  • Edtech
  • Education
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Artisan Partners frequently co-invest with?

Educational Testing Service (ETS)
North America, New Jersey, United States, Princeton
Co-Investments: 1
Narotam Sekhsaria Family Office
Asia, Maharashtra, India, Mumbai
Co-Investments: 1
International Finance Corporation
North America, District of Columbia, United States, Washington
Co-Investments: 1
Temasek Holdings
Asia, Central Region, Singapore, Singapore
Co-Investments: 1
Bain Capital
North America, Massachusetts, United States, Boston
Co-Investments: 1
Kaizenvest
North America, Oregon, United States, Beaverton
Co-Investments: 1
T
North America, New Jersey, United States, Princeton
Co-Investments: 1
EG
Europe, Noord-Holland, The Netherlands, Amsterdam
Co-Investments: 1
BT
North America, Florida, United States, Fort Lauderdale
Co-Investments: 1
IIFL Finance
Asia, Maharashtra, India, Mumbai
Co-Investments: 1

Which angels does Artisan Partners often collaborate with?

Phalgun Kompalli
Asia, Maharashtra, India, Mumbai
Shared Deals: 1
Sunil Bharti Mittal
Asia, Delhi, India, New Delhi
Shared Deals: 1
Ronnie Screwvala
Asia, Maharashtra, India, Mumbai
Shared Deals: 1

What are some of recent deals done by Artisan Partners?

UpGrad

Mumbai, Maharashtra, India

UpGrad is an online higher education platform providing various programs.

E-LearningEdTechEducation
Series UnknownAug 8, 2022
Amount Raised: $205,773,466
Oncopeptides

Stockholm, Stockholms Lan, Sweden

Oncopeptides AB is a privately held clinical stage company developing melflufen, a peptidase potentiated therapy for multiple myeloma.

BiotechnologyClinical TrialsPharmaceutical
Post Ipo EquityMar 10, 2021
Amount Raised: $130,406,997